Show simple item record

dc.contributor.advisorKabir, Eva Rahman
dc.contributor.advisorHossain, M. Zulfiquer
dc.contributor.authorFred, Namanda Rogers
dc.date.accessioned2021-09-15T17:11:53Z
dc.date.available2021-09-15T17:11:53Z
dc.date.copyright2021
dc.date.issued2021-05
dc.identifier.otherID: 17146061
dc.identifier.urihttp://hdl.handle.net/10361/15018
dc.descriptionThis thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.en_US
dc.descriptionCataloged from PDF version of thesis report.
dc.descriptionIncludes bibliographical references (pages 74-87).
dc.description.abstractThis review examines and summarizes major novel immunotherapeutic modalities used in cancer immunotherapy that are currently approved or in clinical trials, as well as their therapeutic potential, side effects, challenges, and future directions The aim of this study was to show different immunotherapeutic modalities used to treat cancer. The mechanism of action of the immune system to combat cancer e.g. Adoptive T cell transfer therapy (TIL, TCR, CAR T Cells), Immune checkpoint inhibitors, monoclonal antibodies cancer vaccines, cytokines and enzyme therapeutic. Second, the study aims to create awareness and provide hope to cancer patients as well as to academics interested in learning more about immunotherapy. Immunotherapy has shown great potential and promise in the treatment of a variety of cancers like solid tumors and hematologic malignancies. Finally, it discusses immunotherapy treatment prospects in the future, including combination therapy.en_US
dc.description.statementofresponsibilityNamanda Rogers Fred
dc.format.extent87 Pages
dc.language.isoen_USen_US
dc.publisherBrac Universityen_US
dc.rightsBrac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.
dc.subjectImmunotherapyen_US
dc.subjectTILen_US
dc.subjectTCRen_US
dc.subjectCAR T Cellsen_US
dc.subjectMonoclonal antibodiesen_US
dc.subjectCheckpoint inhibitorsen_US
dc.titleImmunotherapeutic approaches to treat cancer: Prospects and challengesen_US
dc.typeThesisen_US
dc.contributor.departmentDepartment of Pharmacy, Brac University
dc.description.degreeB. Pharmacy


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record